Skip to main content
Published locations for Adding veliparib to doublet therapy for NSCLC gives slight boost in PFS
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
Adding veliparib to doublet therapy for NSCLC gives slight boost in PFS
User login
Username
Password
Reset your password
/content/adding-veliparib-doublet-therapy-nsclc-gives-slight-boost-pfs
/oncologypractice/article/192546/lung-cancer/adding-veliparib-doublet-therapy-nsclc-gives-slight
/hematology-oncology/article/192546/lung-cancer/adding-veliparib-doublet-therapy-nsclc-gives-slight